Superantigens of Staphylococcus Aureus Colonization in Atopic Dermatitis and Treatment Efficacy of Oral Cefuroxim in Vietnamese Patients
DOI:
https://doi.org/10.3889/oamjms.2019.061Keywords:
Atopic dermatitis, Superantigen, S. aureusAbstract
BACKGROUND: Atopic dermatitis (AD) is a common, chronic, relapsing, genetically determined inflammatory skin disorder. Staphylococcus aureus (S. aureus) plays an important role in the pathogenesis of AD. Atopic skin is susceptible to infection with S. aureus.
AIM: This study was aimed to compare the skin S. aureus colonisation status and its secretion of superantigens in adult AD and healthy subjects and to evaluate the efficacy of two treatment regimens (oral cefuroxime plus topical betamethasone dipropionate 0.05% versus topical betamethasone dipropionate 0.05%) in AD patients.
METHODS: A group of 128 AD and 40 healthy subjects were recruited in this study and treatment efficacy was assessed by the SCORAD score.
RESULTS: S. aureus was found in skin lesions in 83.8% of AD patients while only 37.5% of healthy subjects possessed this kind of bacteria in the external nares (p < 0.001). Superantigen production was more common in S. aureus strains isolated from AD than the control group (58.6% versus 6.6%, p = 0.0006) and staphylococcal enterotoxin B was predominant (88.89%). 68 AD patients who had positive cultures with S. aureus were included in a clinical therapeutic trial. The isolated bacteria were all sensitive to cefuroxime. Patients were randomised to receive either oral cefuroxime 500 mg b.i.d. Plus topical betamethasone dipropionate 0.05% twice daily for 2 weeks (so-called group 1, 36 patients) or only topical betamethasone dipropionate 0.05% twice daily for 2 weeks (so-called group 2, 32 patients). The mean SCORAD scores of group 1 at baseline and after 1 and 2 weeks of treatment were 44.61, 26.69 and 16.61, respectively. The corresponding values for group 2 were 43.03, 32.53 and 23.41, respectively.
CONCLUSION: The reduction in SCORAD scores was significantly higher in group 1 than group 2 in comparison to the baseline value of each study group (p = 0.003 after 1 week and p < 0.001 at the end of treatment).
Downloads
Metrics
Plum Analytics Artifact Widget Block
References
Cork MJ. The role of Staphylococcus aureus in atopic eczema: treatment strategies. Journal of the European Academy of Dermatology and Venereology. 1996; 7: S31-7. https://doi.org/10.1016/0926-9959(96)00030-X
Abeck D, Mempel M. Staphylococcus aureus colonisation in atopic dermatitis and its therapeutic implications. The British journal of dermatology. 1998; 139(53):13-6. https://doi.org/10.1046/j.1365-2133.1998.1390s3013.x PMid:9990408
Higaki S, Morohashi M, Yamagishi T, Hasegawa Y. Comparative study of staphylococci from the skin of atopic dermatitis patients and from healthy subjects. International journal of dermatology. 1999; 38(4):265-9. https://doi.org/10.1046/j.1365-4362.1999.00686.x PMid:10321941
Adachi Y, Akamatsu H, Horio T. The effect of antibiotics on the production of superantigen from Staphylococcus aureus isolated from atopic dermatitis. Journal of dermatological science. 2002; 28(1):76-83. https://doi.org/10.1016/S0923-1811(01)00143-8
Strange P, Skov L, Lisby S, Nielsen PL, Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Archives of dermatology. 1996; 132(1):27-33. https://doi.org/10.1001/archderm.1996.03890250037007 PMid:8546480
Yudate T, Yamada H, Tezuka T. Role of staphylococcal enterotoxins in pathogenesis of atopic dermatitis: growth and expression of T cell receptor Vβ of peripheral blood mononuclear cells stimulated by enterotoxins A and B. Journal of dermatological science. 1996; 13(1):63-70. https://doi.org/10.1016/0923-1811(95)00502-1
Breuer KS, Häussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. British Journal of Dermatology. 2002; 147(1):55-61. https://doi.org/10.1046/j.1365-2133.2002.04872.x PMid:12100185
Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, Yi D, Zhao B. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a doubleâ€blind multicentre randomized controlled trial. British Journal of Dermatology. 2006; 155(4):680-7. https://doi.org/10.1111/j.1365-2133.2006.07410.x PMid:16965415
Goh CL, Wong JS, Giam YC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. International journal of dermatology. 1997; 36(9):653-7. https://doi.org/10.1046/j.1365-4362.1997.00290.x PMid:9352404
McFadden JP, Noble WC, Camp RD. Superantigenic exotoxinâ€secreting potential of staphylococci isolated from atopic eczematous skin. British Journal of Dermatology. 1993; 128(6):631-2. https://doi.org/10.1111/j.1365-2133.1993.tb00257.x PMid:8338746
Boguniewicz M, Sampson H, Leung SB, Harbeck R, Leung DY. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. Journal of Allergy and Clinical Immunology. 2001; 108(4):651-2. https://doi.org/10.1067/mai.2001.118598 PMid:11590398
Weinberg E, Fourie B, Allmann B, Toerien A. The use of cefadroxil in superinfected atopic dermatitis. Current therapeutic research. 1992; 52(5):671-6. https://doi.org/10.1016/S0011-393X(05)80509-0
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 Tro Chau Van, Thang Nguyen Tat, Anh Tran Lan, Thuong Nguyen Van, Marco Gandolfi, Francesca Satolli, Claudio Feliciani, Michael Tirant, Aleksandra Vojvodic, Torello Lotti
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
http://creativecommons.org/licenses/by-nc/4.0
